Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amplyx Cleared To Complete Phase II Study Of New Antifungal Class
Sep 17 2019
•
By
Joseph Haas
Fosmanogepix could offer a new therapy for multiple types of Candida infections
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D